The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction
Open accessAbstract
Converging preclinical, and human epidemiological, neuroimaging, and genetic evidence suggests a central role for dopamine neurotransmission in modulating pain perception and analgesia. Dysregulation in dopamine signaling may modulate the experience of pain both directly, by enhancing or diminishing the propagation of nociceptive signals, and indirectly, by influencing affective and cognitive processes, which affect the expectation, experience, and interpretation of nociceptive signals. Hypersensitivity to pain and high rates of comorbid chronic pain are common in disorders linked with deficits in dopamine system function, including disorders of mood and affect, substance abuse, and Parkinson disease. Hyposensitivity to pain, however, is common in patients with schizophrenia, which has been linked with excessive dopamine neurotransmission. Although patients are typically affected most by the primary symptoms of their disorders, alterations in pain perception may further increase the burden of their illness, compromising their quality of life. The present review focuses on this relationship, and discusses clinical and potential therapeutic implications for both patients with dopamine-related disorders and those with chronic pain syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Crombez, G., Vlaeyen, J. W. S., Heuts, P. H. T. G., & Lysens, R. (1999) · Pain · doi:10.1016/s0304-3959(98)00229-2 · Cited by 1,675
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 1×
“individuals in response to monetary reward (reviewed by [123]).”
BackgroundHow does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505 · cited 1×
“dependent on heroin, cocaine, nicotine, or alcohol (reviewed by [147]).”
BackgroundMultiple dopamine functions at different time courses
Schultz, W. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135722 · Cited by 1,415
Pain catastrophizing: a critical review.
Quartana, P. J., Campbell, C. M., & Edwards, R. R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.34 · Cited by 1,405
Enzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · cited 1×
“For instance, since COMT also plays an important role in degrading norepinephrine and epinephrine [7], it has been suggested that presence of the Val allele may promote more rapid degradation of”
BackgroundDiatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi013 · Cited by 1,280
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244 · cited 1×
“anxiety [135,156] and depression [37].”
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131 · cited 1×
“ence on outcome prediction, attention, response inhibition, and motivation [109], as well as affective symptoms associated with”
BackgroundFloresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review
Fishbain, D. A., Cutler, R., Rosomoff, H. L., & Rosomoff, R. S. (1997) · The Clinical Journal of Pain · doi:10.1097/00002508-199706000-00006 · Cited by 1,074 · cited 1×
“While some differences in DA system function [70], and cognitive [63] and affective symptoms [46] may be secondary to the prolonged experience of pain, other differences may be primary, resulting in altered pain sensitivity or increased vulnerability to”
BackgroundClassical fear-conditioning in the anxiety disorders: a meta-analysis
Lissek, S., Powers, A. S., McClure, E. B., Phelps, E. A., Woldehawariat, G., Grillon, C., & Pine, D. S. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.10.007 · Cited by 1,034 · cited 1×
“In addition, the Met allele of the COMT gene has been associated with the failure to extinguish the response to conditioned fear stimuli [90], a common characteristic of patients with anxiety disorders [89].”
BackgroundIncreased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020
Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events
Horvitz, J. C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00019-1 · Cited by 967
McWilliams, L. A., Cox, B. J., & Enns, M. W. (2003) · Pain · doi:10.1016/s0304-3959(03)00301-4 · Cited by 951
State-dependent opioid control of pain
Fields, H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1431 · Cited by 946 · cited 1×
“While it is well established that endogenous opioids play a key role in modulating these systems [44,175], emerging research implicates central dopamine (DA) signaling as another important”
BackgroundVolkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Fear and anxiety: divergent effects on human pain thresholds
Rhudy, J. L., & Meagher, M. W. (2000) · Pain · doi:10.1016/s0304-3959(99)00183-9 · Cited by 913
A common neurobiology for pain and pleasure
Leknes, S., & Tracey, I. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2333 · Cited by 784 · cited 1×
“gions most commonly implicated in pain processing [4] and brain regions that comprise the DA system [86] (see regions highlighted”
BackgroundBilder, R. M., Volavka, J., Lachman, H. M., & Grace, A. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300542 · Cited by 769
Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum
Heinz, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00099-8 · Cited by 538
Chronic pain patients are impaired on an emotional decision-making task
Apkarian, V. A., Sosa, Y., Krauss, B. R., Thomas, S. P., Fredrickson, B. E., Levy, R. E., Harden, N. R., & Chialvo, D. R. (2004) · Pain · doi:10.1016/j.pain.2003.12.015 · Cited by 536
Rosenblum, A. (2003) · JAMA · doi:10.1001/jama.289.18.2370 · Cited by 523
Individual differences in reward responding explain placebo-induced expectations and effects
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466
Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis
Mier, D., Kirsch, P., & Meyer-Lindenberg, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.36 · Cited by 464 · cited 1×
“Given that allelic variants of the COMT gene may have such wide-reaching influence on neuropharmacological functions, the COMT gene may have pleiotropic effects on a variety of cognitive, affective, and clinical phenotypes [102].”
BackgroundImaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379
Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374
Self-citationPsychological resilience predicts decreases in pain catastrophizing through positive emotions.
Ong, A. D., Zautra, A. J., & Reid, M. C. (2010) · Psychology and Aging · doi:10.1037/a0019384 · Cited by 293 · cited 1×
“with anxiety disorders are more likely than healthy individuals to carry the Met allele [62,71,113,169], the COMT genotype may be an additional mechanism by which the DA system influences anxiety-related symptoms.”
BackgroundPersistent pain is associated with substance use after detoxification: a prospective cohort analysis
Larson, M. J., Paasche‐Orlow, M., Cheng, D. M., Lloyd‐Travaglini, C., Saitz, R., & Samet, J. H. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01759.x · Cited by 204 · cited 1×
“In turn, both pain [19,80] and depression [64] are associated with negative treatment outcomes.”
BackgroundUnderstanding how opioids contribute to reward and analgesia
Fields, H. L. (2007) · Regional Anesthesia and Pain Medicine · doi:10.1097/00115550-200705000-00012 · Cited by 166
The role of motivation in distracting attention away from pain: An experimental study
Verhoeven, K., Crombez, G., Eccleston, C., Van Ryckeghem, D. M. L., Morley, S., & Van Damme, S. (2010) · Pain · doi:10.1016/j.pain.2010.01.019 · Cited by 147
Caldeiro, R. M., Malte, C. A., Calsyn, D. A., Baer, J. S., Nichol, P., Kivlahan, D. R., & Saxon, A. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02358.x · Cited by 122
Cited by
Psychological processing in chronic pain: a neural systems approach
Simons, L. E., Elman, I., & Borsook, D. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.006 · Cited by 359
Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature
Pinheiro, E. S. D. S., Queirós, F. C. D., Montoya, P., Santos, C. L., Nascimento, M. A. D., Ito, C. H., Silva, M., Nunes Santos, D. B., Benevides, S., Miranda, J. G. V., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149085 · Cited by 261
Frontostriatal Gating of Tinnitus and Chronic Pain
Rauschecker, J. P., May, E. S., Maudoux, A., & Ploner, M. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.08.002 · Cited by 253
Pain, decisions, and actions: a motivational perspective
Wiech, K., & Tracey, I. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00046 · Cited by 188
Chang, P.-C., Pollema-Mays, S. L., Centeno, M. V., Procissi, D., Contini, M., Baria, A. T., Martina, M., & Apkarian, A. V. (2014) · Pain · doi:10.1016/j.pain.2014.02.019 · Cited by 161
“Moreover, in patients with central disorders such as schizophrenia, Parkinson’s disease, substance abuse, and mood and anxiety disorders, pain sensitivity is altered, presumably as a consequence of changes in the dopaminergic system [1,42,71], and animal studies implicate dopamine in acute and neuropathic conditions […”
Background
Metadata
- Authors
- Jarcho, J. M., Mayer, E. A., Jiang, Z. K., Feier, N. A., & London, E. D.
- Venue
- Pain
- Published
- 2012-04
- Volume
- 153
- Issue
- 4
- Pages
- 744-754
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2170447689
- Cited by
- 158
- References
- 37
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.